Cirurgia Cardíaca
Diretrizes para anestesiologistas sobre o manejo do sangue do paciente em cirurgia cardíaca.
18 Out, 2021 | 08:46h
Comentário no Twitter
Please check out editorial on patient #blood management in #cardiacsurgery, a collaboration between Society of Thoracic Surgeons, Society of Cardiovascular Anestheisologists and SABM, AmSECT. https://t.co/HHA8SjxNot pic.twitter.com/DAj2TrGYC3
— Jiapeng Huang (@jiapenghuang) September 24, 2021
Extensão variada da disjunção anular mitral entre casos com diferentes fenótipos de prolapso de valva mitral.
8 Out, 2021 | 11:32h
Comentário no Twitter
Varied Extent of #MAD Among Cases With Different Phenotypes of #Mitral Valve #Prolapse ➡️ 3D #YesCCT ➡️ https://t.co/7q4GqIAZQd @JACCJournals @UCLA @argulian @purviparwani @MinnowWalsh @BakhshiHooman @MrinShettyMD @mividovich #JACCCaseReports @gina_lundberg @chiarabd @EstefaniaOS pic.twitter.com/6gVnaBg3cb
— Julia Grapsa (@JGrapsa) August 18, 2021
Revisão | Anomalias de artéria coronária.
1 Out, 2021 | 18:32hCoronary Artery Anomalies – Circulation (gratuito por tempo limitado)
Comentário no Twitter
#InDepth Review highlighting current diagnostic and therapeutic approaches to Coronary Artery Anomalies https://t.co/TB5HWvgHiE #AHAJournals pic.twitter.com/OaCGUNSPfW
— Circulation (@CircAHA) September 23, 2021
#ESCCongress | Diretrizes 2021 da ESC/EACTS para tratamento da doença cardíaca valvar – Nas novas diretrizes, mais pacientes são elegíveis a intervenções cirúrgicas e transcateter, com base não somente nos sintomas, mas também em critérios de imagem.
30 Ago, 2021 | 13:27hComunicado de imprensa: European valvular heart disease Guidelines published today – European Society of Cardiology
Resumo: 2021 ESC/EACTS Valvular Heart Disease Guidelines: Key Points – American College of Cardiology
Comentário: Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. – MedPage Today (necessário cadastro gratuito)
“In line with recent U.S. recommendations, the newest European guidelines favor a wider pool of patients eligible for surgical and transcatheter interventions for valvular heart disease.” (from MedPage Today)
Comentários no Twitter
#ESCCongress new VHD guidelines out ➡️https://t.co/fFkuivAM9E
➡️SAVR in low risk pts <75yrs old
➡️ TAVR in pts >75
➡️ Role of heart team emphasised
➡️ NEW! intervention to be considered with asymptomatic AS with lv <55% IIa@HanCardiomd @Hragy @aayshacader @DrMarthaGulati #TAVR pic.twitter.com/JV1zocQJaK— Mamas Mamas (@mmamas1973) August 28, 2021
🆕Guidelines for the management of valvular heart disease #ESCCongress @escardio @secardiologia @EACTS
📂 https://t.co/3FCS8YYKIr @mmamas1973 @shci_sec pic.twitter.com/wxuf3AjVaE
— Alfonso Valle (@ValleAlfonso) August 28, 2021
Optimal antithrombotic therapy for valve prostheses from the 2021 #ESC Guidelines for the management of VHD #ESCCongress @escardio https://t.co/AmQJkZBMoo pic.twitter.com/WK2wQSSlhL
— Roxana Mehran (@Drroxmehran) August 28, 2021
(thread – click for more)
Have there been changes in when to intervene with the new 2021 ESC/EACTS guidelines for the management of valvular heart disease?
Yes, and in general the bar for intervention is now lower
Thread follows…#ESCCongress
1/n pic.twitter.com/iLN9cLCtLj
— Sarah Hudson (@sarahhudsonuk) August 28, 2021
Uso de drogas por doadores não está associado com piora na sobrevida do receptor de transplante cardíaco – “Aumento do uso de tais doadores pode ajudar a aliviar a escassez crônica de doadores.”
2 Ago, 2021 | 17:58hIntoxicated Donors and Heart Transplant Outcomes: Long-Term Safety – Circulation: Heart Failure
Comentário: Donor Drug Use Not Tied to Survival for Heart Transplant Recipients – HealthDay
Estudo relacionado: National Trends in Heart Donor Usage Rates: Are We Efficiently Transplanting More Hearts? – Circulation: Heart Failure
Consenso ESC | Terapias antitrombóticas nas doenças arteriais aórticas e periféricas em 2021.
2 Ago, 2021 | 16:44hPontos principais a lembrar: ESC Consensus on Antithrombotic Therapies in Aortic and Peripheral Artery Diseases – American College of Cardiology
Comentário no Twitter
The new consensus document from the ESC working group on aorta and peripheral vascular diseases on best antithrombotic strategies!#aorta #antithrombotic #therapy #EHJ #cardiotwitter@escardio @ESC_Journals https://t.co/ga17wxKDGi pic.twitter.com/CSSgE5TFdX
— EHJ Editor-in-Chief (@ehj_ed) July 23, 2021
Consenso de especialistas | Exames de imagem na análise da viabilidade miocárdica.
2 Ago, 2021 | 16:36hConteúdo relacionado: Review | Myocardial perfusion and viability imaging in coronary artery disease: clinical value in diagnosis, prognosis and therapeutic guidance.
Comentário no Twitter
Proud to be actor of the EACVI expert consensus document about MMI of myocardial viability.
Congratulations to @bernhard_gerber for the magnificent job as work leader!https://t.co/wewpY5BVGQ@carpenter_jp @DonalErwan @sven_plein @denisamuraru @maceiraCMR @MarcDweck @unisiena pic.twitter.com/kdxZL3wQxW— Matteo Cameli, MD, PhD (@Matte_Cameli) June 8, 2021
Diretriz de consenso internacional sobre a nomenclatura e a classificação da válvula aórtica bicúspide congênita e sua aortopatia para fins clínicos, cirúrgicos, intervencionistas e de pesquisa.
26 Jul, 2021 | 10:08h
Comentário no Twitter
Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve https://t.co/Uux9d40kkj pic.twitter.com/LA8dfuWv90
— CM Otto (@ottoecho) July 22, 2021
Posicionamento de sociedades de cardiologia sobre a biópsia endomiocárdica.
23 Jul, 2021 | 10:08h
Comentário no Twitter
🚨A must read – out now in JCF: Position Statement on Endomyocardial Biopsy 🫀 – @HFSA @escardio @ESCardioNews #CardioTwitter #FunctionNotFailure #HeartSuccess @rcstarling @MRMehraMD @BiykemB @Filippatos @robmentz @dranulala https://t.co/33FPZDBviN pic.twitter.com/VJEzGLIRIg
— Journal of Cardiac Failure (@JCardFail) July 21, 2021
OMS divulga novas recomendações sobre a edição do genoma humano para o avanço da saúde pública.
13 Jul, 2021 | 11:20hVer relatórios:
Human genome editing: recommendations
Human genome editing: a framework for governance
Comentários: New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases – Health Policy Watch E WHO should lead on genome-editing policy, advisers say – Nature E WHO Calls for Global Registry of Human Genome Editing – HealthDay E Expert reaction to the WHO’s newly published recommendations and governance framework for human genome editing – Science Media Centre
Comentário no Twitter (fio – clique para saber mais)
Two 🆕 reports provide the first global recommendations to help establish human genome 🧬 editing as a tool for public health, with an emphasis on safety, effectiveness and ethics.
👉 https://t.co/w32QhMXSXi pic.twitter.com/Bto9SF6NzW
— World Health Organization (WHO) (@WHO) July 12, 2021